Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ALEXZA PHARMACEUTICALS INC Financial Overview

  • Income Statement: ALXA

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 486,000.00 0.00 486,000.00 100.00%
    Gross Profit -4.81 M -4.02 M -792,000.00 16.47%
    Net Income Before Extra Items/Preferred Div -58.45 M -45.12 M -13.33 M 22.81%
    Operating Income -78.72 M -60.53 M -18.19 M 23.10%
  • Cash Flow: ALXA

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 6.92 M 70.09 M -63.16 M -912.23%
    Net Cash Flow - Investing -42.85 M 19.95 M -62.80 M 146.57%
    Net Cash Flow/Operating Activities -55.07 M -35.83 M -19.24 M 34.94%
  • Balance Sheet: ALXA

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 84.64 M 149.12 M -64.49 M -76.20%
    Total Liabilities 45.58 M 49.18 M -3.60 M -7.90%
    Shareholders Equity 33.69 M 75.99 M -42.30 M -125.54%
  • Key Ratios / Statistics: ALXA

    • Valuation

      Price/Earnings (TTM) -1.75
      Price/Sales (TTM) 210.63
      Price/Book (MRQ) 3.00
      Price/Cash Flow (TTM) -1.34
    • Profitability

      Gross Margin -989.30
      Operating Margin -16,197.53
      Profit Margin -12,026.75
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 3.42
      Current Ratio (MRQ) 2.24
      Long Term Debt-to-Equity (MRQ) 4.53
    • Management Effectiveness

      Return on Equity (TTM) -104.41
      Return on Assets (TTM) -46.88
      Return on Investments (TTM) -73.89